Venus Medtech International’s Post

Cheers to PI Dr. Dany Jacob, Dana King, Eric Burgett, Hall Jamie, and the rest of the MICRO2 study team at Saint Luke's Health System on enrolling their first MICRO2 patient! Prior to the initiation of the MICRO2 trial, the recently published MICRO trial demonstrated CardioFlux MCG's ability to diagnose coronary microvascular dysfunction (CMD) in the space of a 90-second, no-contact scan - a first-of-its-kind exploration in what is now six decades of research into MCG. In contrast, the current gold standard for diagnosis is invasive coronary functional angiography, an option which remains practically out-of-reach for a majority of patients who likely suffer from CMD today. Worse still, clinician recognition of CMD and its impact on long-term outcomes remains low, perhaps due in part to the lack of simple, highly accessible options for diagnosis today. We’re excited to partner with clinicians, like Dr. Jacob and the rest of his team, who are actively working to address this unmet need! #MICRO2 #CardioFluxMCG #microvascular #CMD #myocardialischemia #INOCA

Even in the most complex lesions, #BioMimics3D continues to demonstrate durable results through three years of follow-up. Please join Veryan Medical at #NCVH May 28-31, booth #321, to learn the latest on outcomes in the most complex patients. Walter Penny Jack Sullivan Joe DeJohn New Cardiovascular Horizons

Now presenting at #InnovationDublin24 is ORIXHA with CEO Fabrice PAUBLANT.   Orixha’s (Maisons-Alfort, France) mission is to develop Liquid Ventilation Medical Devices to save lives in Critical Care. Orixha develops Vent2Cool based on its proprietary Lung Conservative Liquid Ventilation to shield the critical organs (brain, heart) from reperfusion injury. Vent2Cool improves survival and morbidity outcomes of Post Cardiac Arrest Syndrome by transforming the lungs into an efficient heat exchanger with the circulating blood to induce ultra-rapid therapeutic hypothermia – reaching the 33°C protective temperature within minutes vs. hours with current hypothermia devices. Orixha’s proprietary total liquid ventilation technology platform, once validated in therapeutic hypothermia, will be developed for other Critical Care conditions such as Acute Respiratory Distress Syndrome. Orixha is disrupting the critical care landscape for the ventilation of patients with cardiac arrest and respiratory distress. Orixha’s unique approach delivers total liquid ventilation, resting the alveoli and avoiding inflammatory stress in the lungs.     Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

An exciting IVC 2025! Learn how to be successful and DIVERSIFY your practice for the future.

🚀 Excited to share this insightful video featuring Dr. Olivier Taton, a leading pulmonologist, presenting Iriscope – a groundbreaking tool designed to revolutionize lung diagnostics! Iriscope enables detailed visual exploration of peripheral lung lesions, offering a non-invasive way to diagnose complex lung conditions with greater precision and clarity. 🌟 In this video, Dr. Taton walks us through the technology, demonstrating its impact on early detection and patient care in pulmonology. Check out the video below to learn how Iriscope is transforming the future of lung health! 🔍🫁 #Pulmonology #LungHealth #MedicalInnovation #Iriscope #HealthcareTechnology #Diagnostics #PrecisionMedicine #DrOlivierTaton

Christie Ballantyne MD, extends this invitation for YOU to attend the 19th Annual Cardiometabolic Health Congress at the iconic Boston Park Plaza, from October 17-19, 2024. CMHC's comprehensive agenda is designed to address your most pressing questions in this rapidly evolving field, with discussions on: 💔 The intricate links between cardiovascular, renal, and metabolic health. 💊 The latest therapeutic agents and innovations poised to transform patient outcomes. 💓 An evidence-based deep dive into the relationship between inflammation and atherosclerosis, featuring keynote speaker Dr. Peter Libby, leading authority on the subject. 🔗 Secure your spot today: https://lnkd.in/edDMQy9z #CMHC #CardiometabolicHealthCongress #CMHC19thAnnual #CMHCAnnual2024 #DecodeTheConstellation #CardiometabolicMedicine #HeartHealth #PatientCare #Healthcare #Health #HeartDisease #Atherosclerosis #Inflammation #Cardiology #Cardiologist

Genetesis Launches CardioFlux Membership Program to Revolutionize Preventive Cardiac Care and Eliminate Heart Disease https://lnkd.in/gmyXZYCZ Proactive, personalized monitoring of myocardial fitness at regular intervals, powered by MCG technology, represents paradigm shift in the prevention of heart disease City of Mason’s Biohealth Corridor selected as home of first ever CardioFlux Imaging [...]

World Muscle Society (WMS) Conference 2024 is taking place next week, October 8th – 12th. Our CEO Lauren Morgenroth will be joined by Director of Strategic Solutions Ana Christensen to attend the top respected gathering in the neuromuscular field. WMS brings together leading researchers, clinicians, and industry experts to share the latest developments in research, treatment, and patient care. For those navigating the complex landscape of rare neuromuscular diseases, this event is an opportunity to exchange knowledge and gain insights into emerging therapies and clinical approaches. Our involvement in this global event is part of a broader mission to provide access to groundbreaking research and compassionate, patient-centered care. Our team’s participation is a testament to our continuous efforts to make meaningful progress in understanding and treating neuromuscular conditions. #WMS2024 #WorldMuscleSociety # ClinicalResearchOrganization #ClinicalTrials #DuchenneAwareness #MuscularDystrophy #MuscularDystrophyResearch #RareDiseaseResearch #ResearchForACure #PatientDrivenResearch

𝐋𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐲𝐨𝐮𝐫 𝐇𝐄𝐀𝐑𝐓: 𝐓𝐚𝐤𝐞 𝐂𝐨𝐧𝐭𝐫𝐨𝐥 𝐓𝐨𝐝𝐚𝐲! As heart disease continues to be a leading global health challenge, innovative technologies are at the forefront of improving outcomes and enhancing patient care. Advanced imaging techniques allow us to visualize heart conditions with unprecedented clarity, leading to earlier and more accurate diagnoses. Advanced interventional solutions help healthcare professionals by covering needs across clinical pathways. From blood tests that reveal vital biomarkers to cutting-edge genetic screenings, lab diagnostics provide invaluable insights into heart health. Moreover, advancements in point-of-care testing are making it possible to deliver rapid results, allowing for timely interventions that can save lives. These insights from data-driven solutions and AI-powered diagnostics, empower healthcare professionals to create personalized treatment plans tailored to each patient’s unique needs. By continuously innovating technologies we at Siemens Healthineers are transforming how we approach cardiovascular care, for everyone, everywhere. Sustainably. On this World Heart Day let's pledge to make a difference and protect the heart we love. Explore our connected cardiovascular care solutions: https://lnkd.in/eSJCf9dz #SiemensHealthineers #WorldHeartDay #UseHeartforAction

Elevate your emergency and critical care skills at #VetScienceWeek24. Dive into expert-led sessions on cutting-edge topics like pulmonary hypertension, cardiac arrhythmias, mechanical ventilation and more. Hear the latest research and clinical insights to enhance your care for the most critical patients. View the #VSW24 program and register today! 🌐https://lnkd.in/gN2SZUNd #ANZCVS #vetscience #VedEducation #Vet #emergencyvet